Element Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-89,566
Closed -$6.37M 48
2023
Q3
$6.37M Sell
89,566
-17,613
-16% -$1.32M 0.57% 47
2023
Q2
$8.26M Buy
107,179
+5,748
+6% +$445K 0.56% 43
2023
Q1
$7.62M Buy
+101,431
New +$7.54M 0.58% 49
2022
Q4
Sell
-15,071
Closed -$1.06M 52
2022
Q3
$1.06M Hold
15,071
0.51% 48
2022
Q2
$1.21M Buy
15,071
+5,024
+50% +$393K 0.61% 41
2022
Q1
$762K Sell
10,047
-268,409
-96% -$21.3M 0.38% 57
2021
Q4
$23.8M Buy
+278,456
New +$21.7M 1.53% 19
2019
Q3
Sell
-21,955
Closed -$1.57M 242
2019
Q2
$1.57M Buy
21,955
+18,044
+461% +$1.28M 0.11% 180
2019
Q1
$268K Buy
+3,911
New +$253K 0.01% 634
2016
Q3
Sell
-13,863
Closed -$1.01M 77
2016
Q2
$1.01M Sell
13,863
-974
-7% -$69.4K 0.15% 102
2016
Q1
$1.05M Sell
14,837
-811
-5% -$54K 0.16% 110
2015
Q4
$1.04M Buy
15,648
+4,502
+40% +$299K 0.2% 69
2015
Q3
$707K Buy
11,146
+8,346
+298% +$545K 0.26% 65
2015
Q2
$183K Buy
+2,800
New +$190K 0.07% 147

Other funds holding CL

Element Capital Management's CL Position: Q4 2023 in Review

Element Capital Management sold out of Colgate-Palmolive (CL) in Q4 2023, closing a stake of 89,566 shares — an estimated $6.37M sold.

Element Capital Management first reported a position in CL in Q2 2015 and held it in 14 quarters. The position peaked at $23.8M in Q4 2021. 1,741 funds tracked by Wall St. Rank hold CL as of Q4 2023.

  • Element Capital Management reported no remaining Colgate-Palmolive position as of Q4 2023 after selling out during the quarter.
  • Element Capital Management sold 89,566 Colgate-Palmolive shares in Q4 2023, an estimated $6.37M.
  • Element Capital Management first reported a position in Colgate-Palmolive in Q2 2015 and held it in 14 quarters.
  • Element Capital Management's Colgate-Palmolive position peaked at $23.8M in Q4 2021.
  • 1,741 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.